Serum concentration of C-reactive protein is not a good marker of bronchial hyperresponsiveness

Archivum Immunologiae et Therapiae Experimentalis

Volumn 55, Issue 5, 2007, Pages 341-345

  Panaszek, Bernard ^a   Liebhart, Ewa ^a   Liebhart, Jerzy ^a   Pawłowicz, Robert ^a   Fal, Andrzej M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Asthma; Asthmatic inflammation; BHR; Corrao syndrome; High sensitivity CRP; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; HISTAMINE;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; ASTHMA; BIOLOGICAL MARKERS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION; MALE; MIDDLE AGED;

EID: 38349187842     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-007-0035-5     Document Type: Article

References (27)

1. Abramson J. L., Lewis C., Murrah N. V., Anderson G. T. and Vaccarino V. (2006): Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults. Am. J. Cardiol., 98, 649-652.
2. Anderson J. L., Allen Maycock C. A., Lappe D. L., Crandall B. G., Horne B. D., Bair T. L., Morris S. R., Li Q. and Muhlestein J. B. (2004): Frequency of elevation of C-reactive protein in atrial fibrillation. Am. J. Cardiol., 94, 1255-1259.
3. Bazzino O., Ferreiros E. R., Pizarro R. and Corrado G. (2001): C-reactive protein and the stress tests for the risk stratification of patients recovering from unstable angina pectoris. Am. J. Cardiol., 87, 1235-1239.
4. Bottcher M. F., Bjurstrom J., Mai X. M., Nilsson L. and Jenmalm M. C. (2003): Allergen-induced cytokine secretion in atopic and non-atopic asthmatic children. Pediatr. Allergy Immunol., 14, 345-350.
5. Fal A. M., Dobek R., Liebhart J., Panaszek B. and Małolepszy J. (2004): Complex assessment of differential cell count in bronchoalveolar lavage fluid as a distinction criterion between asthma and chronic obstructive pulmonary disease. Adv. Clin. Exp. Med., 13, 67-71.
6. Green R. H., Brightling C. E., McKenna S., Hargadon B., Parker D., Bradding P., Wardlaw A. J. and Paword I. D. (2002): Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet, 360, 1715-1721.
7. Herz U., Ruckert R., Wollenhaupt K., Tschernig T., Neuhaus-Steinmetz U., Pabst R. and Renz H. (1999): Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness - a model for non-allergic asthma. Eur. J. Immunol., 29, 1021-1031.
8. Jousilahti P., Salomaa V., Hakala K., Rasi V., Vahtera E. and Palosuo T. (2002): The association of sensitive systemic inflammation markers with bronchial asthma. Ann. Allergy Asthma Immunol., 89, 381-385.
9. Kony S., Zureik M., Driss F., Neukirch C., Leynaert B. and Neukirch F. (2004): Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax, 59, 892-896.
10. Liebhart J., Cembrzynska-Nowak M., Bienkowska M., Liebhart E., Dobek R., Zaczyńska E., Panaszek B., Obojski A. and Małolepszy J. (2002): Relevance of the selected cytokine release (TNF-alpha, IL-6, IFN-gamma, and IFN-alpha) to the exacerbation of bronchial asthma from airway mycotic infections. Predominant role of IFN-alpha? J. Investig. Allergol. Clin. Immunol., 12, 182-191.
11. Lo B., Fijnheer R., Nierich A. P., Bruins P. and Kalkman C. J. (2005): C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann. Thorac. Surg., 79, 1530-1535.
12. Lowe G. D., Sweetnam P. M., Yarnell J. W., Rumley A., Rumley C., Bainton D. and Ben-Shlomo Y. (2004): C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies. Arterioscler. Thromb. Vasc. Biol., 24, 1957-1962.
13. NO). Pneumonol. Alergol. Pol., 72, 181-186.
14. Michel O., Ginanni R., Le Bon B., Content J., Duchateau J. and Sergysels R. (1992): Inflammatory response to acute inhalation of endotoxin in asthmatic patients. Am. Rev. Respir. Dis., 146, 352-357.
15. Nieves A., Magnan A., Boniface S., Proudhon H., Lanteaume A., Romanet S., Vervolet D. and Godard P. (2005): Phenotypes of asthma revisited upon the presence of atopy. Respir. Med., 99, 347-354.
16. Nogami H., Shoji S. and Nishima S. (2003): Exhaled nitric oxide as a simple assessment of airway hyperresponsiveness in bronchial asthma and chronic cough patients. J. Asthma, 40, 653-659.
17. Ólafsdottir I. S., Gislason T., Thjodleifsson B., Olafsson Í., Gislason D., Jögi R. and Janson C. (2005): C reactive protein levels are increased in non-allergic but not in allergic asthma: a multicentre epidemiological study. Thorax, 60, 451-454.
18. Ramirez M., Garcia-Rio F., Vinas A., Prados C., Pino J. M. and Villamor J. (2004): Relationship between exhaled carbon monoxide and airway hyperresponsiveness in asthmatic patients. J. Asthma, 41, 109-116.
19. Sterk P. J., Fabbri L. M., Quanjer P. H., Cockroft D. W., O'Byrne P. M., Anderson S. D., Juniper E. F. and Malo J. L. (1993): Standardized challenge testing with pharmacological physical and sensitizing stimuli in adults. Report working party standardization of lung function tests. European Community for Steal and Coal. Official statement of the European Respiratory Society. Eur. Respir. J., 6 (suppl.), 1653-1683.
20. Szalai A. J. (2004): C-reactive protein (CRP) and autoimmune disease: facts and conjectures. Clin. Dev. Immunol., 11, 221-226.
21. Szalai A. J., Nataf S., Hu X. Z. and Barnum S. R. (2002): Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J. Immunol., 168, 5792-5797.
22. Taha R. A., Laberge S., Hamid Q. and Olivenstein R. (2001): Increased expression of the chemoattractant cytokines eotaxin, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients. Chest, 120, 595-601.
23. Tedeschi A., Comi A.L., Lorini M., Tosini C. and Miadonna A. (2005): Autologous serum skin test reactivity in patients with non-allergic asthma. Clin. Exp. Allergy, 35, 849-853.
24. Trigg C. J., Nicholson K. G., Wang J. H., Ireland D. C., Jordan S., Duddle J. M., Hamilton S. and Davies R. J. (1996): Bronchial inflammation and the common cold: a comparison of atopic and non-atopic individuals. Clin. Exp. Allergy, 26, 665-676.
25. Weidinger S., Klopp N., Rummler L., Wagenpfeil S., Baurecht H. J., Gauger A., Darsow U., Jakob T., Ollert M., Behrendt H., Wichmann H. E., Ring J. and Illig T. (2005): Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults. Clin. Exp. Allergy, 35, 866-872.
26. Yin W. H., Chen J. W., Jen H. L., Chiang M. C., Huang W. P., Feng A. N., Young M. S. and Lin S. J. (2004): Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am. Heart J., 147, 931-938.
27. Zureik M., Kony S., Neukirch C., Courbon D., Leynaert B., Vervloet D., Ducimetiere P. and Neukirch F. (2004): Bronchial responsiveness to methacholine is associated with increased common carotid intima-media thickness in men. Arterioscler. Thromb. Vasc. Biol., 24, 1098-1103.